relapsing multiple sclerosis
-
New OCREVUS Data Demonstrate Significant Reductions in Disease Activity in MS
The new OCREVUS® (ocrelizumab) data were presented at the 70th American Academy of Neurology (AAN) Annual Meeting from April 21-27…
Read More »